InvestorsHub Logo
Followers 34
Posts 3288
Boards Moderated 0
Alias Born 07/12/2007

Re: None

Friday, 11/23/2007 1:20:43 PM

Friday, November 23, 2007 1:20:43 PM

Post# of 11073
ReBuilder Medical Technologies, Inc.'s Recent Stock Price Volatility Explained
PR NEWSWIRE
Posted: 2007-11-23 12:52:25
CHARLES TOWN, W.Va., Nov. 23 /PRNewswire-FirstCall/ -- ReBuilder Medical Technologies, Inc. (Pink Sheets: RBRM), a provider of treatment for diabetic peripheral neuropathy and Molluscum Contagiosum, today announced it has successfully concluded analysis of the recent volatility of their stock price and presented it to the Board of Directors.

(Logo: http://www.newscom.com/cgi-bin/prnh/20061128/REBUILDERLOGO )

It appears that several institutional and corporate investors possibly got nervous over the sub-prime housing crisis and liquidated large portions of their portfolios. "Unfortunately, our equity was included in their programmed liquidation process. As a result, many individual investors followed suit, increasing the supply of stock available to purchase and driving down the price per share," according to David Phillips, Ph.D. CEO.

Meanwhile the company continued its steady growth as evidenced by the quarterly reports published on pinksheets.com. There was no bad news whatsoever relative to the actual operations of the company. "We are in better financial shape, in better marketing shape, in better R&D shape, and in better PR shape than ever before in our company's history," says Dr. Phillips.

"We have successfully renegotiated certain aspects of our original merger terms to reduce the possibility of any remaining large corporate holders of our equities from taking profits and dumping large blocks of our stock on the market. In addition, many of these original holders of large blocks of our equities have now liquidated the majority of their shares to individual investors. We expect that these new individuals may have the best long-term interests of our company in mind. This could have the desired effect of stabilizing the stock price and thus reflect the real value of our equities," states Dr. Phillips. He concluded his statement by saying, "Because I, personally, am an insider, I cannot buy my own company's stock. However, if I could, I would sell my dog if I had to, to buy some."

Beginning on Monday, November 26, 2007, RBRM will be releasing a series of twelve news releases that will describe several new initiatives that are very exciting and will help investors have a better understanding of the company's current success and plans to expand that success in the near future.